Show simple item record

Preclinical Evaluation of [18F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters

dc.contributor.authorTesta, Andrea
dc.contributor.authorDall'Angelo, Sergio
dc.contributor.authorMingarelli, Marco
dc.contributor.authorAugello, Andrea
dc.contributor.authorSchweiger, Lutz
dc.contributor.authorWelch, Andrew
dc.contributor.authorElmore, Charles S
dc.contributor.authorDawson, Dana
dc.contributor.authorSharma, Pradeep
dc.contributor.authorZanda, Matteo
dc.date.accessioned2018-08-08T15:07:07Z
dc.date.available2018-08-08T15:07:07Z
dc.date.issued2018-07-30
dc.identifier.citationTesta , A , Dall'Angelo , S , Mingarelli , M , Augello , A , Schweiger , L , Welch , A , Elmore , C S , Dawson , D , Sharma , P & Zanda , M 2018 , ' Preclinical Evaluation of [ 18 F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters ' , Contrast Media & Molecular Imaging , vol. 2018 , 3064751 . https://doi.org/10.1155/2018/3064751en
dc.identifier.issn1555-4317
dc.identifier.otherPURE: 119483936
dc.identifier.otherPURE UUID: f8a479c9-52dc-46d2-b391-3a824f65aabe
dc.identifier.otherPubMed: 30154685
dc.identifier.otherScopus: 85051518403
dc.identifier.otherPubMedCentral: PMC6091370
dc.identifier.urihttp://hdl.handle.net/2164/10875
dc.descriptionAcknowledgements: A.T. gratefully acknowledges SINAPSE (www.sinapse.ac.uk) and AstraZeneca (UK) for co-funding a studentship. P.S. and C.S.E. are employees of AstraZeneca Ltd., UK. This project has also received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 675417.en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofContrast Media & Molecular Imagingen
dc.rightsCopyright © 2018 Andrea Testa et al. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/en
dc.subjectR Medicine (General)en
dc.subjectEuropean Commissionen
dc.subject675417en
dc.subject.lccR1en
dc.titlePreclinical Evaluation of [18F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transportersen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Kosterlitz Centre for Therapeuticsen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Energyen
dc.contributor.institutionUniversity of Aberdeen.Medical Educationen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Biomedical Imaging Centreen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1155/2018/3064751


Files in this item

Thumbnail
Name:
Preclinical_Evaluation_of_18F_ ...
Size:
2.984Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record